Fluoxetine is a 2nd generation antidepressant categorized as a selective serotonin reuptake inhibitor (SSRI). It gained FDA approval in 1987 and although it was initially intended for the treatment of depression, today it is commonly prescribed to manage depression in addition to various other pathologies.
Fluoxetine is indicated for both acute and maintenance treatment of major depressive disorder, obsessive compulsive disorder, and bulimia nervosa; however, it is only indicated for acute treatment of panic disorder independent of whether agoraphobia is present. Fluoxetine may also be used in combination with olanzapine to treat depression related to Bipolar ...
University of Alabama at Birmingham, Birmingham, Alabama, United States
Gartnavel Royal Hospital, 1055 Great Western Road, Glasgow, United Kingdom
The Walton Centre, Liverpool, United Kingdom
Derriford Hospital, Plymouth, United Kingdom
Federal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil
Beijing Anding Hospital, Beijing, Beijing, China
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tokyo, Japan
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Tokyo, Japan
University of Minnesota, Department of Psychiatry, Minneapolis, Minnesota, United States
Shanghai Mental Health Center, Shanghai, China
Emory Executive Park, Atlanta, Georgia, United States
Hospital General de Zona #1, Aguascalientes, Mexico
Antiguo Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico
Instituto Nacional de Neurología y Neurocirugía, Mexico City, Mexico
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.